PubMed

Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes.

van Wijk JP, de Koning EJ, Castro Cabezas M, Rabelink TJ.

Diabetes Care. 2005 Apr;28(4):844-9.PMID: 15793183 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of rosiglitazone on postprandial leukocytes and cytokines in type 2 diabetes.

van Wijk JP, Cabezas MC, Coll B, Joven J, Rabelink TJ, de Koning EJ.

Atherosclerosis. 2006 May;186(1):152-9. Epub 2005 Aug 30.PMID: 16137694 [PubMed - indexed for MEDLINE]Related articles

Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.

Skrapari I, Perrea D, Ioannidis I, Karabina SA, Elisaf M, Tselepis AD, Karagiannacos P, Katsilambros N.

Diabet Med. 2001 Oct;18(10):781-5.PMID: 11678967 [PubMed - indexed for MEDLINE]Related articles

The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes.

Tan GD, Fielding BA, Currie JM, Humphreys SM, Désage M, Frayn KN, Laville M, Vidal H, Karpe F.

Diabetologia. 2005 Jan;48(1):83-95. Epub 2004 Dec 24.PMID: 15619071 [PubMed - indexed for MEDLINE]Related articles

Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.PMID: 17211855 [PubMed - indexed for MEDLINE]Related articles

Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.

Lund SS, Tarnow L, Frandsen M, Smidt UM, Pedersen O, Parving HH, Vaag AA.

Eur J Endocrinol. 2008 Jan;158(1):35-46.PMID: 18166815 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone modulates fasting and post-prandial paraoxonase 1 activity in type 2 diabetic patients.

van Wijk J, Coll B, Cabezas MC, Koning E, Camps J, Mackness B, Joven J.

Clin Exp Pharmacol Physiol. 2006 Dec;33(12):1134-7.PMID: 17184491 [PubMed - indexed for MEDLINE]Related articles

Acute effect of orlistat on post-prandial lipaemia and free fatty acids in overweight patients with Type 2 diabetes mellitus.

Tan KC, Tso AW, Tam SC, Pang RW, Lam KS.

Diabet Med. 2002 Nov;19(11):944-8.PMID: 12421432 [PubMed - indexed for MEDLINE]Related articles

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483. PMID: 16861090 [PubMed - indexed for MEDLINE]Related articles

Comparative effects of rosiglitazone and pioglitazone on fasting and postprandial low-density lipoprotein size and subclasses in patients with Type 2 diabetes.

Berneis K, Rizzo M, Stettler C, Chappuis B, Braun M, Diem P, Christ ER.

Expert Opin Pharmacother. 2008 Feb;9(3):343-9.PMID: 18220486 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with type II diabetes.

Raskin P, Rappaport EB, Cole ST, Yan Y, Patwardhan R, Freed MI.

Diabetologia. 2000 Mar;43(3):278-84.PMID: 10768088 [PubMed - indexed for MEDLINE]Related articles

Postprandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content.

Cooper MB, Tan KC, Hales CN, Betteridge DJ.

Diabet Med. 1996 Sep;13(9):816-27.PMID: 8891457 [PubMed - indexed for MEDLINE]Related articles

Effects of simvastatin on fasting and postprandial triglyceride-rich lipoproteins in patients with type I diabetes mellitus.

Noutsou M, Georgopoulos A.

J Diabetes Complications. 1999 Mar-Apr;13(2):98-104.PMID: 10432174 [PubMed - indexed for MEDLINE]Related articles

Effects of metformin or rosiglitazone on serum concentrations of homocysteine, folate, and vitamin B12 in patients with type 2 diabetes mellitus.

Sahin M, Tutuncu NB, Ertugrul D, Tanaci N, Guvener ND.

J Diabetes Complications. 2007 Mar-Apr;21(2):118-23.PMID: 17331860 [PubMed - indexed for MEDLINE]Related articles

Postprandial hyperlipidemia after a fat loading test in minority adolescents with type 2 diabetes mellitus and obesity.

Umpaichitra V, Banerji MA, Castells S.

J Pediatr Endocrinol Metab. 2004 Jun;17(6):853-64.PMID: 15270403 [PubMed - indexed for MEDLINE]Related articles

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes.

Matikainen N, Mänttäri S, Schweizer A, Ulvestad A, Mills D, Dunning BE, Foley JE, Taskinen MR.

Diabetologia. 2006 Sep;49(9):2049-57. Epub 2006 Jul 1.PMID: 16816950 [PubMed - indexed for MEDLINE]Related articles

A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia.

Goldberg RB, Kendall DM, Deeg MA, Buse JB, Zagar AJ, Pinaire JA, Tan MH, Khan MA, Perez AT, Jacober SJ; GLAI Study Investigators.

Diabetes Care. 2005 Jul;28(7):1547-54.PMID: 15983299 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes.

Mori Y, Itoh Y, Obata T, Tajima N.

Endocrine. 2006 Feb;29(1):143-8.PMID: 16622303 [PubMed - indexed for MEDLINE]Related articles

Effects of a cardioselective beta-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk.

Boquist S, Ruotolo G, Hellénius ML, Danell-Toverud K, Karpe F, Hamsten A.

Atherosclerosis. 1998 Apr;137(2):391-400.PMID: 9622282 [PubMed - indexed for MEDLINE]Related articles

Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?

Battula SB, Fitzsimons O, Moreno S, Owens D, Collins P, Johnson A, Tomkin GH.

Metabolism. 2000 Aug;49(8):1049-54.PMID: 10954025 [PubMed - indexed for MEDLINE]Related articles